Top Suppliers:I want be here

66529-17-7

66529-17-7 structure
66529-17-7 structure
  • Name: Midaglizole
  • Chemical Name: Midaglizole
  • CAS Number: 66529-17-7
  • Molecular Formula: C16H17N3
  • Molecular Weight: 251.32600
  • Catalog: Signaling Pathways GPCR/G Protein Adrenergic Receptor
  • Create Date: 2018-09-17 17:48:09
  • Modify Date: 2024-01-02 18:29:14
  • Midaglizole ((±)-DG5128 free base, DG5128 free base) is a potent α2-adrenoceptor antagonist. Midaglizole is a hypoglycemic agent. Midaglizole increases blood pressure and reduces blood glucose levels in vivo[1][2][3].

Name Midaglizole
Synonyms 2-[2-(2-Imidazolin-2-yl)-1-phenylethyl]pyridine
2-[2-Phenyl-2-(pyridyl)]ethyl-2-imidazolin
2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenyl-1-[2]pyridyl-ethane
4,5-Dihydro-2-[2-(2-pyridinyl)-2-phenylethyl]-1H-imidazole
DG-5128
2-(4,5-Dihydro-1H-imidazol-2-yl)-1-phenyl-1-[2]pyridyl-aethan
2-(2-phenyl-2-(2-pyridyl))ethyl-2-imidazoline
Description Midaglizole ((±)-DG5128 free base, DG5128 free base) is a potent α2-adrenoceptor antagonist. Midaglizole is a hypoglycemic agent. Midaglizole increases blood pressure and reduces blood glucose levels in vivo[1][2][3].
Related Catalog
In Vitro Midaglizole stimulates insulin release with the EC50 values of 200 nM, 24 µM for rat islets and MIN6 β-cell line, respectively[3].
In Vivo Midaglizole (3, 30 mg/kg; i.v.) increases blood pressure in rats[1]. Midaglizole (0.2, 1, 2 mg/kg; infusion) reduces blood glucose levels in dags[2]. Animal Model: 290-450 g, Male Wistar rats[1] Dosage: 3, 30 mg/kg Administration: I.v. Result: Increased the blood pressure by 27 and 64 mmHg at 3, 30 mg/kg, respectively. Animal Model: Dogs[2] Dosage: 0.2, 1, 2 mg/kg Administration: Superior pancreaticoduodeneal artery infusion Result: Reduced blood glucose levels by stimulating insulin release from the pancreatic islets.
References

[1]. Hirohashi M, et al. Intrinsic pressor activity of midaglizole, an alpha-2 adrenoceptor antagonist, in pithed rats. Jpn J Pharmacol. 1990 Aug;53(4):519-20.  

[2]. Ohneda K, et al. Mechanism of insulin secretion by midaglizole. Diabetes Res Clin Pract. 1993 Feb;19(2):127-32.  

[3]. Proks P, et al. Inhibition of recombinant K(ATP) channels by the antidiabetic agents midaglizole, LY397364 and LY389382. Eur J Pharmacol. 2002 Sep 27;452(1):11-9.  

Density 1.14g/cm3
Boiling Point 460ºC at 760 mmHg
Molecular Formula C16H17N3
Molecular Weight 251.32600
Flash Point 232ºC
Exact Mass 251.14200
PSA 37.28000
LogP 2.36970
Index of Refraction 1.629
HS Code 2933990090

~97%

66529-17-7 structure

66529-17-7

Literature: Ishikawa Chemical and pharmaceutical bulletin, 1980 , vol. 28, # 5 p. 1394 - 1402

~%

66529-17-7 structure

66529-17-7

Literature: Ishikawa Chemical and pharmaceutical bulletin, 1980 , vol. 28, # 5 p. 1394 - 1402

~%

66529-17-7 structure

66529-17-7

Literature: Ishikawa Chemical and pharmaceutical bulletin, 1980 , vol. 28, # 5 p. 1394 - 1402

~67%

66529-17-7 structure

66529-17-7

Literature: Ishikawa Chemical and pharmaceutical bulletin, 1980 , vol. 28, # 5 p. 1394 - 1402

~%

66529-17-7 structure

66529-17-7

Literature: Sperber; Fricano Journal of the American Chemical Society, 1953 , vol. 75, p. 2986

~%

66529-17-7 structure

66529-17-7

Literature: Ishikawa Chemical and pharmaceutical bulletin, 1980 , vol. 28, # 5 p. 1394 - 1402

~%

66529-17-7 structure

66529-17-7

Literature: Schering Corp. Patent: US2604473 , 1950 ;
HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%